The TY1 Stabilizer Pancreas is designed to help stabilize blood sugars for Type 1 diabetics. This small device is inserted into the stomach area of the body and routinely checks glucose levels. Insulin in shot into the stomach from the device based on blood glucose levels. For dangerously low blood sugars glucose is shot into the stomach to prevent extremities such as loss of consciousness. Senors placed inside The T1 Stabilizer notify the device to check blood sugar levels when blood glucose become dangerously high or low. The TY1 Stabilizer has its own personal app that can capture blood glucose readings and hemoglobin A1C. These recordings make it more convenient for the patient/ and physician to track and monitor glucose levels.
Why is the T1 Stabilizer considered an artificial pancreas. When a pancreas is fully functional insulin is released from the beta cells in the pancreas in response to rising glucose in your bloodstream. The pancreas detects this rise in blood glucose and starts to secrete insulin. In type 1 diabetes, the pancreas, stops making insulin because beta cells that make the insulin have been destroyed by the body's immune system.
The T1 Stabilizer will act upon high glucose levels very similar to the pancreas. In addition to this the T1 Stabilizer has the ability to treat low blood sugars as well.
Until Scientist create a way to get the pancreas to produces new beta cells/islets that will not be destroyed into a non functional pancreas. Stabilizing the blood is the best practice/ therapy to treat type 1 diabetes.
ABOUT THE ENTRANT
Name: Detra Lewis
Type of entry: individual
Detra's hobbies and activities:
Hiking, reading, traveling
Detra is inspired by:
I've been a type 1 diabetic for 20 years now. I have been through the lows of this disease. I had to endure extremely high blood sugars and I've been in situations where my blood sugar was extremely low and with nothing in arms reach to raise my blood sugar level.Until a cure is found I want to make life easier, safer and more convenient for billions type 1 diabetics around the world.
Patent status: pending